Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalMarket CapitalizationReturn on AssetsReturn on Capital EmployedReturn on Equity

Compass Therapeutics (CMPX) Return on Assets: 2023-2025

Historic Return on Assets for Compass Therapeutics (CMPX) over the last 2 years, with Sep 2025 value amounting to -0.40%.

  • Compass Therapeutics' Return on Assets fell 8.00% to -0.40% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.40%, marking a year-over-year decrease of 8.00%. This contributed to the annual value of -0.38% for FY2024, which is N/A change from last year.
  • As of Q3 2025, Compass Therapeutics' Return on Assets stood at -0.40%, which was up 24.85% from -0.54% recorded in Q2 2025.
  • In the past 5 years, Compass Therapeutics' Return on Assets registered a high of -0.26% during Q4 2023, and its lowest value of -0.54% during Q2 2025.
  • For the 3-year period, Compass Therapeutics' Return on Assets averaged around -0.36%, with its median value being -0.34% (2024).
  • Data for Compass Therapeutics' Return on Assets shows a maximum YoY declined of 24bps (in 2025) over the last 5 years.
  • Compass Therapeutics' Return on Assets (Quarterly) stood at -0.26% in 2023, then decreased by 10bps to -0.36% in 2024, then declined by 8bps to -0.40% in 2025.
  • Its Return on Assets stands at -0.40% for Q3 2025, versus -0.54% for Q2 2025 and -0.43% for Q1 2025.